Clorox (CLX) Receivables - Other (2012 - 2025)

Clorox's Receivables - Other history runs 14 years deep, the most recent figure standing at $16.0 million for Q2 2025.

• On a quarterly basis, Receivables - Other fell 58.97% year-over-year to $16.0 million in Q2 2025; TTM through Jun 2025 was $16.0 million, a 58.97% decrease from a year earlier, with the FY2025 full-year figure at $16.0 million, down 58.97% from the prior year.
• Receivables - Other fell to $16.0 million in Q2 2025 per CLX's latest filing, from $39.0 million in the prior quarter.
• Across five years, Receivables - Other topped out at $39.0 million in Q2 2024 and bottomed at $14.0 million in Q2 2023.
• The 5-year median for Receivables - Other is $22.0 million (2021), against an average of $22.6 million.
• Across the five-year window, Receivables - Other jumped 178.57% in 2024 and sank 58.97% in 2025, its largest moves.
• Year by year, Receivables - Other stood at $22.0 million in 2021, then changed by 0.0% to $22.0 million in 2022, then plunged by 36.36% to $14.0 million in 2023, then soared by 178.57% to $39.0 million in 2024, then sank by 58.97% to $16.0 million in 2025.
• Per Business Quant, the three latest CLX Receivables - Other figures stand at $16.0 million (Q2 2025), $39.0 million (Q2 2024), and $14.0 million (Q2 2023).